InsiderClue
Insiders · Profile

Gagnon Robert E.

Chief Financial Officer at Opus Genetics · Director at Verastem · Chief Financial Officer at HARVARD BIOSCIENCE · and 1 more. Filing since 6 Dec 2010. CIK 0001504983

IRD Opus Genetics, Inc. Chief Financial Officer · 3 trades VSTM Verastem, Inc. Director · 30 trades HBIO HARVARD BIOSCIENCE INC Chief Financial Officer · 18 trades BIIB Biogen Vice President, Finance · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IRD Opus Genetics, Inc.
3 Sep 2026
Chief Financial Officer
Sold at will
28,000
$127.21K
4.8%
IRD Opus Genetics, Inc.
23 Jul 2026
Chief Financial Officer
Sold at will
7,783
$22.94K
1.3%
IRD Opus Genetics, Inc.
23 Apr 2026
Chief Financial Officer
Sold at will
7,842
$40.66K
1.3%
VSTM Verastem, Inc.
16 Dec 2025
Director
Sold on a plan
283
$2.59K
0.7%
VSTM Verastem, Inc.
16 Sep 2025
Director
Sold on a plan
281
$2.81K
0.7%
VSTM Verastem, Inc.
16 Jun 2025
Director
Sold at will
284
$1.60K
0.7%
VSTM Verastem, Inc.
17 Mar 2025
Director
Sold at will
284
$1.97K
0.8%
VSTM Verastem, Inc.
19 Dec 2024
Director
Sold at will
130
$568.10
0.4%
VSTM Verastem, Inc.
16 Dec 2024
Director
Sold at will
285
$1.29K
0.8%
VSTM Verastem, Inc.
19 Sep 2024
Director
Sold at will
131
$365.49
0.4%
VSTM Verastem, Inc.
16 Sep 2024
Director
Sold at will
287
$803.60
0.8%
VSTM Verastem, Inc.
20 Jun 2024
Director
Sold at will
131
$420.51
0.4%
VSTM Verastem, Inc.
17 Jun 2024
Director
Sold at will
283
$987.67
1.0%
VSTM Verastem, Inc.
19 Mar 2024
Director
Sold at will
130
$1.35K
0.5%
VSTM Verastem, Inc.
18 Mar 2024
Director
Sold at will
283
$3.03K
1.0%
VSTM Verastem, Inc.
6 Feb 2024
Director
Sold on a plan
9,204
$126.09K
24.9%
VSTM Verastem, Inc.
12 Jan 2024
Director
Sold on a plan
9,204
$100.78K
19.9%
VSTM Verastem, Inc.
19 Dec 2023
Director
Sold at will
130
$1.00K
0.3%
VSTM Verastem, Inc.
18 Dec 2023
Director
Sold at will
284
$2.17K
0.6%
VSTM Verastem, Inc.
19 Sep 2023
Director
Sold at will
130
$1.28K
0.3%
VSTM Verastem, Inc.
18 Sep 2023
Director
Sold at will
278
$2.75K
0.6%
VSTM Verastem, Inc.
20 Jun 2023
Director
Sold at will
130
$1.34K
0.3%
VSTM Verastem, Inc.
16 Jun 2023
Director
Sold at will
283
$2.81K
0.6%
VSTM Verastem, Inc.
20 Mar 2023
Director
Sold at will
1,664
$715.52
0.3%
VSTM Verastem, Inc.
16 Mar 2023
Director
Sold at will
3,654
$1.46K
0.6%
VSTM Verastem, Inc.
19 Dec 2022
Director
Sold, plan not stated
1,429
$528.73
0.2%
VSTM Verastem, Inc.
16 Dec 2022
Director
Sold, plan not stated
12,408
$4.96K
2.1%
VSTM Verastem, Inc.
19 Sep 2022
Chief Financial Officer
Sold, plan not stated
1,348
$1.52K
0.2%
VSTM Verastem, Inc.
21 Jun 2022
Chief Financial Officer
Sold, plan not stated
1,351
$1.54K
0.2%
VSTM Verastem, Inc.
16 May 2022
Chief Financial Officer
Sold, plan not stated
16,627
$17.13K
2.7%
VSTM Verastem, Inc.
21 Mar 2022
Chief Financial Officer
Sold, plan not stated
1,409
$1.79K
0.3%
VSTM Verastem, Inc.
3 Jan 2022
Chief Financial Officer
Sold, plan not stated
19,612
$40.20K
3.4%
VSTM Verastem, Inc.
20 Dec 2021
Chief Financial Officer
Sold, plan not stated
5,497
$12.48K
0.9%
HBIO HARVARD BIOSCIENCE INC
29 Aug 2018
Chief Financial Officer
Sold, plan not stated
8,889
$51.29K
2.7%
HBIO HARVARD BIOSCIENCE INC
7 Aug 2018
Chief Financial Officer
Sold, plan not stated
100,015
$608.09K
22.3%
HBIO HARVARD BIOSCIENCE INC
27 Jul 2018
Chief Financial Officer
Sold, plan not stated
62,514
$346.33K
14.7%
HBIO HARVARD BIOSCIENCE INC
24 Jul 2018
Chief Financial Officer
Sold, plan not stated
5,570
$29.24K
1.5%
HBIO HARVARD BIOSCIENCE INC
23 Jul 2018
Chief Financial Officer
Sold, plan not stated
1,465
$7.69K
0.4%
HBIO HARVARD BIOSCIENCE INC
19 Jul 2018
Chief Financial Officer
Sold, plan not stated
1,100
$5.78K
0.3%
HBIO HARVARD BIOSCIENCE INC
13 Jul 2018
Chief Financial Officer
Sold, plan not stated
1,062
$5.58K
0.3%
HBIO HARVARD BIOSCIENCE INC
12 Jul 2018
Chief Financial Officer
Sold, plan not stated
9,145
$48.01K
2.3%
HBIO HARVARD BIOSCIENCE INC
11 Jul 2018
Chief Financial Officer
Sold, plan not stated
141,300
$739.00K
26.8%
HBIO HARVARD BIOSCIENCE INC
10 Jul 2018
Chief Financial Officer
Sold, plan not stated
13,700
$73.71K
3.2%
HBIO HARVARD BIOSCIENCE INC
9 Jul 2018
Chief Financial Officer
Sold, plan not stated
14,200
$76.82K
3.3%
HBIO HARVARD BIOSCIENCE INC
7 Mar 2018
Chief Financial Officer
Sold, plan not stated
97,087
$448.54K
21.3%
HBIO HARVARD BIOSCIENCE INC
26 May 2017
Chief Financial Officer
Bought
1,000
$2.33K
0.2%
HBIO HARVARD BIOSCIENCE INC
3 Nov 2016
Chief Financial Officer
Bought
20,000
$46.80K
8.1%
HBIO HARVARD BIOSCIENCE INC
2 Nov 2016
Chief Financial Officer
Bought
5,000
$11.65K
2.1%
HBIO HARVARD BIOSCIENCE INC
12 Nov 2015
Chief Financial Officer
Bought
1,500
$4.40K
2.3%
HBIO HARVARD BIOSCIENCE INC
9 Nov 2015
Chief Financial Officer
Bought
3,000
$9.24K
4.7%
HBIO HARVARD BIOSCIENCE INC
16 Jun 2014
Chief Financial Officer
Bought
5,000
$19.28K
opened
BIIB Biogen
29 Feb 2012
Vice President, Finance
Sold, plan not stated
717
$82.82K
15.2%
BIIB Biogen
28 Feb 2012
Vice President, Finance
Sold, plan not stated
835
$96.05K
15.0%
BIIB Biogen
24 Feb 2012
Vice President, Finance
Sold, plan not stated
1,054
$121.77K
15.2%
BIIB Biogen
14 Feb 2012
Vice President, Finance
Sold, plan not stated
560
$66.42K
10.0%
BIIB Biogen
6 Dec 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
795
$89.29K
13.6%
BIIB Biogen
9 Nov 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
796
$89.18K
11.4%
BIIB Biogen
5 Oct 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
252
$24.61K
3.3%
BIIB Biogen
3 Oct 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
778
$72.00K
9.2%
BIIB Biogen
6 May 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
967
$92.96K
11.1%
BIIB Biogen
4 May 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
215
$20.65K
2.4%
BIIB Biogen
2 Mar 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
1,402
$98.16K
12.9%
BIIB Biogen
24 Feb 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
1,054
$70.61K
8.6%
BIIB Biogen
17 Feb 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
732
$49.12K
6.5%
BIIB Biogen
4 Jan 2011
Chief Acct Officer VP & Contr
Sold, plan not stated
5,103
$339.69K
32.1%
BIIB Biogen
6 Dec 2010
Chief Acct Officer VP & Contr
Sold, plan not stated
796
$52.96K
6.4%
66 decisions on file.